Compare FIVE & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | FIVE | BAX |
|---|---|---|
| Founded | 2002 | 1931 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Department/Specialty Retail Stores | Medical/Dental Instruments |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.0B | 10.2B |
| IPO Year | 2012 | 1994 |
| Metric | FIVE | BAX |
|---|---|---|
| Price | $232.58 | $17.98 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 20 | 9 |
| Target Price | ★ $236.00 | $21.00 |
| AVG Volume (30 Days) | 1.1M | ★ 6.0M |
| Earning Date | 06-03-2026 | 04-30-2026 |
| Dividend Yield | N/A | ★ 0.22% |
| EPS Growth | ★ 40.65 | N/A |
| EPS | ★ 6.47 | N/A |
| Revenue | $4,764,147,000.00 | ★ $11,244,000,000.00 |
| Revenue This Year | $14.44 | $1.96 |
| Revenue Next Year | $9.37 | $2.22 |
| P/E Ratio | $36.04 | ★ N/A |
| Revenue Growth | ★ 22.90 | 5.72 |
| 52 Week Low | $73.92 | $15.73 |
| 52 Week High | $251.63 | $32.68 |
| Indicator | FIVE | BAX |
|---|---|---|
| Relative Strength Index (RSI) | 53.36 | 51.64 |
| Support Level | $213.25 | $17.69 |
| Resistance Level | $235.08 | $18.97 |
| Average True Range (ATR) | 8.64 | 0.61 |
| MACD | 0.01 | 0.11 |
| Stochastic Oscillator | 52.07 | 51.89 |
Five Below Inc is a specialty value retailer offering a broad range of trend-right, high-quality products loved by the kid and the kid in all of customers. The Company's edited assortment of products includes select brands and licensed merchandise. The Company also sells its merchandise on the internet, through the Company's e-commerce website and mobile app, offering home delivery and the option to buy online and pick up in store. Additionally, the Company sells merchandise through on-demand third-party delivery services to enable its customers to shop online and receive convenient delivery. It derives revenue from sales of the Company's merchandise to customers.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.